David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

CNBC’s Jim Cramer delivers his daily Mad Dash.

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to ...

Preview this article 1 min A Madrid, Spain-based cancer diagnostic firm seeks to grow its footprint to 21,000-square-foot at ...

Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interestFollowing successful Phase 1 clinical results, global discussions on OVM-200 expandMeetings with over 40 ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

A House committee wants answers from major drugmakers about their China clinical trial practices. The deadline is tighter ...

The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers ...

Abivax Announces Closing of $920 Million Public Offering PARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a ...

Shares rose 5% after the biotech moved to bolster its balance sheet through an upsized stock offering, signaling investor ...

Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.